- [Financial Times] Will poor countries get the coronavirus treatments they need?
- Letter from US lawmakers on public funding of Remdesivir to US HHS Secretary Azar
- [Follow the Money] Roche releases recipe, after European Commission considers intervention due to lack of coronavirus tests
- [The Times of India] United we will be saved: Global leadership is needed to push pharma solutions and distribute them at affordable prices
- [South Centre] Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock
Category Archives: BRICS
Breaking news for access to biological medicines – Brazilian court nixes biological drug eculizumab patent, says more could follow
Source: BioCentury | April 21, 2018 A Brazilian court unanimously ruled Friday to remove patent protection for Soliris eculizumab from Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), opening the door for production of biosimilar versions in the country. In a statement, Brazil’s Attorney General Office said … Continue reading
On Thursday 16 November 2017, Russian president Vladimir Putin told a hall full of health ministers in Moscow that TB is a “serious problem”, and said, “I am confident that the only way we can stand up against this truly global threat … Continue reading
Public health targets should be placed above trade deals, says J.P. Nadda By Vidya Krishnan, The Hindu | December 17, 2016 Union Health Minister J.P. Nadda has pressed for public health targets to be placed above trade deals. “Trade regimes … Continue reading
Iol news, Nobember 19, 2015. US and European pharmaceutical industries see South Africa as “ground zero” for keeping their large profit margins, say Julia Hill and Catherine Tomlinson.
Tackling Antimicrobial Resistance Is an Area BRIC Countries Can Lead the World – They Must Take This Opportunity
Huffington Post; November 12, 2015. Brazil, India, Russia and China have gone through a period of rapid economic development, making them important global players in the 21st century. However, they are also the countries that might be affected most severely by growing antimicrobial … Continue reading
Source: Business Line Thanks to the India-US Intellectual Property Working Group. Here’s how — and why this is bad news for India’s poor Prime Minister Narendra Modi’s first official visit to the US included several meetings with industry representatives and … Continue reading
Source: Pharmalot In recent months, two countries with large economies and large populations both took steps to rework their patent laws, in part, to expand access to medicines. The moves come amid increasing concerns that treatments for certain ailments, such … Continue reading